BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 25332207)

  • 1. GRK5-mediated exacerbation of pathological cardiac hypertrophy involves facilitation of nuclear NFAT activity.
    Hullmann JE; Grisanti LA; Makarewich CA; Gao E; Gold JI; Chuprun JK; Tilley DG; Houser SR; Koch WJ
    Circ Res; 2014 Dec; 115(12):976-85. PubMed ID: 25332207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining the absolute requirement of G protein-coupled receptor kinase 5 for pathological cardiac hypertrophy: short communication.
    Gold JI; Gao E; Shang X; Premont RT; Koch WJ
    Circ Res; 2012 Sep; 111(8):1048-53. PubMed ID: 22859683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncovering G protein-coupled receptor kinase-5 as a histone deacetylase kinase in the nucleus of cardiomyocytes.
    Martini JS; Raake P; Vinge LE; DeGeorge BR; Chuprun JK; Harris DM; Gao E; Eckhart AD; Pitcher JA; Koch WJ
    Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12457-62. PubMed ID: 18711143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Role of G Protein-Coupled Receptor Kinase 5 in Physiological Versus Pathological Cardiac Hypertrophy.
    Traynham CJ; Cannavo A; Zhou Y; Vouga AG; Woodall BP; Hullmann J; Ibetti J; Gold JI; Chuprun JK; Gao E; Koch WJ
    Circ Res; 2015 Dec; 117(12):1001-12. PubMed ID: 26515328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear translocation of cardiac G protein-Coupled Receptor kinase 5 downstream of select Gq-activating hypertrophic ligands is a calmodulin-dependent process.
    Gold JI; Martini JS; Hullmann J; Gao E; Chuprun JK; Lee L; Tilley DG; Rabinowitz JE; Bossuyt J; Bers DM; Koch WJ
    PLoS One; 2013; 8(3):e57324. PubMed ID: 23472081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A peptide of the N terminus of GRK5 attenuates pressure-overload hypertrophy and heart failure.
    Coleman RC; Eguchi A; Lieu M; Roy R; Barr EW; Ibetti J; Lucchese AM; Peluzzo AM; Gresham K; Chuprun JK; Koch WJ
    Sci Signal; 2021 Mar; 14(676):. PubMed ID: 33785612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PH domain leucine-rich repeat protein phosphatase 2 (PHLPP2) regulates G-protein-coupled receptor kinase 5 (GRK5)-induced cardiac hypertrophy
    Yeh ST; Zambrano CM; Koch WJ; Purcell NH
    J Biol Chem; 2018 May; 293(21):8056-8064. PubMed ID: 29628444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Amino-Terminal Domain of GRK5 Inhibits Cardiac Hypertrophy through the Regulation of Calcium-Calmodulin Dependent Transcription Factors.
    Sorriento D; Santulli G; Ciccarelli M; Maione AS; Illario M; Trimarco B; Iaccarino G
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29543709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of nuclear factor κB (NF-κB) in the nucleus of cardiomyocytes by G protein-coupled receptor kinase 5 (GRK5).
    Islam KN; Bae JW; Gao E; Koch WJ
    J Biol Chem; 2013 Dec; 288(50):35683-9. PubMed ID: 24174526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition.
    Maning J; McCrink KA; Pollard CM; Desimine VL; Ghandour J; Perez A; Cora N; Ferraino KE; Parker BM; Brill AR; Aukszi B; Lymperopoulos A
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G protein-coupled receptor kinase 5 (GRK5) contributes to impaired cardiac function and immune cell recruitment in post-ischemic heart failure.
    de Lucia C; Grisanti LA; Borghetti G; Piedepalumbo M; Ibetti J; Lucchese AM; Barr EW; Roy R; Okyere AD; Murphy HC; Gao E; Rengo G; Houser SR; Tilley DG; Koch WJ
    Cardiovasc Res; 2022 Jan; 118(1):169-183. PubMed ID: 33560342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between NFκB and NFAT coordinates cardiac hypertrophy and pathological remodeling.
    Liu Q; Chen Y; Auger-Messier M; Molkentin JD
    Circ Res; 2012 Apr; 110(8):1077-86. PubMed ID: 22403241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways.
    Liu W; Deng J; Ding W; Wang G; Shen Y; Zheng J; Zhang X; Luo Y; Lv C; Wang Y; Chen L; Yan D; Boudreau RL; Song LS; Liu J
    Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of HuR downstream of p38 MAPK promotes cardiomyocyte hypertrophy.
    Slone S; Anthony SR; Wu X; Benoit JB; Aube J; Xu L; Tranter M
    Cell Signal; 2016 Nov; 28(11):1735-41. PubMed ID: 27521603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel role of G protein-coupled receptor kinase 5 in urotensin II-stimulated cellular hypertrophy in H9c2
    Park CH; Lee JH; Lee MY; Lee JH; Lee BH; Oh KS
    Mol Cell Biochem; 2016 Nov; 422(1-2):151-160. PubMed ID: 27613164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear effects of G-protein receptor kinase 5 on histone deacetylase 5-regulated gene transcription in heart failure.
    Zhang Y; Matkovich SJ; Duan X; Gold JI; Koch WJ; Dorn GW
    Circ Heart Fail; 2011 Sep; 4(5):659-68. PubMed ID: 21768220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced expression of DYRK1A in cardiomyocytes inhibits acute NFAT activation but does not prevent hypertrophy in vivo.
    Grebe C; Klingebiel TM; Grau SP; Toischer K; Didié M; Jacobshagen C; Dullin C; Hasenfuss G; Seidler T
    Cardiovasc Res; 2011 Jun; 90(3):521-8. PubMed ID: 21273244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GRK5 is a regulator of fibroblast activation and cardiac fibrosis.
    Eguchi A; Coleman R; Gresham K; Gao E; Ibetti J; Chuprun JK; Koch WJ
    Proc Natl Acad Sci U S A; 2021 Feb; 118(5):. PubMed ID: 33500351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
    Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
    Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O-GlcNAc signaling is essential for NFAT-mediated transcriptional reprogramming during cardiomyocyte hypertrophy.
    Facundo HT; Brainard RE; Watson LJ; Ngoh GA; Hamid T; Prabhu SD; Jones SP
    Am J Physiol Heart Circ Physiol; 2012 May; 302(10):H2122-30. PubMed ID: 22408028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.